Ethical rehab marketing practices are advertising and outreach methods that give patients accurate information, protect patient privacy, and comply with federal laws governing addiction treatment referrals. Three federal frameworks define the boundary between ethical and unethical rehab marketing: the Eliminating Kickbacks in Recovery Act (EKRA), the Federal Trade Commission’s enforcement authority under the Opioid Addiction Recovery Fraud Prevention Act (OARFPA), and the confidentiality rules in 42 CFR Part 2 and HIPAA. Treatment centers that violate these frameworks face criminal penalties, FTC lawsuits, and advertising account suspensions. This guide lists nine specific practices that keep a treatment center’s marketing program compliant and trustworthy.
Key Takeaways
- Ethical rehab marketing practices rest on three federal frameworks: EKRA (patient brokering), FTC/OARFPA (deceptive advertising), and HIPAA/42 CFR Part 2 (patient confidentiality).
- EKRA makes it a federal felony to pay or receive remuneration for patient referrals to a recovery home, clinical treatment facility, or laboratory, with penalties up to $200,000 and 10 years imprisonment.
- The FTC sued Mercury Marketing and settled with Evoke Wellness in 2025 for running search ads that impersonated other treatment clinics and rerouted callers.
- Google, Meta, and Microsoft Advertising all require addiction treatment advertisers to hold third-party certification before running ads, on top of federal law.
- 42 CFR Part 2’s 2024 final rule requires documented patient consent before substance use disorder records are used for any purpose, including marketing testimonials.
- Lead generation built on purchased contact lists or unverified outcome claims exposes a treatment center to both FTC and state attorney general action.
- A compliance audit covering claims, consent documentation, referral payments, and ad certification status catches most ethical marketing violations before they trigger enforcement.
What Are Ethical Rehab Marketing Practices?
Ethical rehab marketing practices are methods of advertising and patient outreach that comply with federal anti-kickback, consumer protection, and confidentiality law while giving prospective patients truthful information. The category exists because addiction treatment marketing intersects with people making treatment decisions during a health crisis, often for themselves or a family member. Congress and the FTC treat this intersection as high-risk and have built specific statutes around it, unlike marketing rules for most other service industries. A marketing practice only qualifies as ethical when it satisfies both the legal standard and the trust standard: it must be lawful, and it must not exploit a person’s vulnerability to convert them into a lead.
Why Rehab Marketing Has Its Own Legal Category
Addiction treatment marketing developed a distinct regulatory category because the opioid crisis produced a documented pattern of patient brokering, in which lead generators and unlicensed call centers sold addicted individuals to the highest-bidding treatment center regardless of clinical fit. Congress responded with EKRA in 2018. The FTC responded with expanded enforcement authority under OARFPA. Digital ad platforms responded by requiring third-party certification before allowing addiction treatment ads to run at all. No comparable three-layer enforcement structure exists for most other healthcare marketing categories, which is why generic marketing compliance knowledge does not transfer directly to rehab marketing.
The Legal Framework Behind Ethical Rehab Marketing
Three federal frameworks govern rehab marketing simultaneously, and each targets a different type of violation.
| Framework | What It Regulates | Enforcement Body |
|---|---|---|
| EKRA (18 U.S.C. § 220) | Payments or kickbacks for patient referrals to recovery homes, treatment facilities, or labs | U.S. Department of Justice |
| OARFPA / FTC Act | Deceptive or unsubstantiated claims in substance use disorder advertising | Federal Trade Commission |
| 42 CFR Part 2 and HIPAA | Use of patient records and identifiable patient information in marketing materials | SAMHSA and HHS Office for Civil Rights |
EKRA prohibits patient brokering by making it a federal felony to solicit, pay, or receive remuneration for referring a patient to a recovery home, clinical treatment facility, or laboratory. Congress passed EKRA in 2018 as part of the SUPPORT for Patients and Communities Act, specifically to close a loophole that let treatment centers pay per-referral fees to marketers and call centers. EKRA applies to all payers, not only government health programs, which distinguishes it from the older Anti-Kickback Statute. Violations carry penalties of up to $200,000 in fines and 10 years in prison per violation.
The FTC enforces OARFPA against treatment centers and marketers that make deceptive claims or impersonate competitors in advertising. The FTC’s Division of Advertising Practices brought two major substance use disorder marketing cases in June 2025 alone: a settlement with Evoke Wellness over search ads that impersonated other clinics’ phone numbers, and a lawsuit against Mercury Marketing for the same impersonation tactic across multiple defendant clinics. Both cases involved callers who searched for one treatment center by name and were rerouted to a different, unrelated facility.
42 CFR Part 2 and the HIPAA Privacy Rule restrict how patient information appears in marketing content, including testimonials. The HIPAA Privacy Rule requires patient authorization before protected health information is used in marketing communications, per HHS.gov guidance. SAMHSA’s 2024 final rule on 42 CFR Part 2 requires a documented, patient-signed consent before substance use disorder treatment records are disclosed for any purpose, with enforcement of the updated rule beginning February 2026.
9 Ethical Rehab Marketing Practices Treatment Centers Must Follow
The following nine practices translate the three legal frameworks above into specific, actionable marketing decisions.
1. Base Every Claim on Verified, Evidence-Based Outcomes
Ethical rehab marketing states only outcome claims that a treatment center can substantiate with documented clinical data. The FTC requires advertisers to hold competent and reliable evidence for any health claim before publishing it, and addiction treatment claims receive additional scrutiny under OARFPA. Terms such as “cure,” “guaranteed recovery,” or a specific unverified success percentage expose a center to FTC action, as seen in the agency’s smoking-cessation and opioid-treatment product cases. A compliant claim cites the specific data source and time period behind any success statistic.
2. Obtain Documented Consent Before Publishing Patient Stories
Every patient testimonial, before-and-after narrative, or case study requires a signed, revocable consent form under 42 CFR Part 2 and HIPAA before it appears in marketing materials. General educational content about treatment modalities does not require this consent because it contains no protected health information tied to an identifiable patient. A treatment center should keep signed consent records on file for the duration any testimonial remains published, and remove the content promptly if a patient revokes consent.
3. Refuse Patient Brokering and EKRA-Covered Referral Payments
Ethical rehab marketing never pays a marketer, call center, or referring individual a fee tied to the number of patients admitted. EKRA criminalizes this exchange regardless of whether the payment comes from the treatment center, an affiliate marketer, or a third-party lead broker. Acceptable alternatives include flat-fee advertising placements, salaried admissions staff, and licensed clinical referral relationships that involve no per-patient payment.
4. Disclose Costs, Insurance Coverage, and Admissions Terms Upfront
Transparent marketing states accepted insurance carriers, typical out-of-pocket costs, and admissions requirements before a prospective patient calls, rather than withholding this information to force a phone conversation. Hidden fees and vague cost language are a recurring theme in deceptive-advertising complaints against treatment marketers. Publishing verification-of-benefits information and a clear admissions process on a treatment center’s website reduces both consumer complaints and wasted admissions calls.
5. Build Lead Generation on Explicit Opt-In, Never Purchased Lists
Ethical lead generation contacts only individuals who explicitly requested information through a form, phone call, or chat the person initiated. Purchased contact lists and cold outreach to numbers scraped from unrelated sources create both a compliance risk and a patient-trust risk, since the recipient never consented to being contacted about addiction treatment. Consent records for every inbound lead should specify what the person agreed to and when.
6. Avoid Ad Targeting That Exploits Vulnerability
Ethical ad targeting avoids parameters that single out people in acute financial distress, recent legal trouble, or crisis-level vulnerability for aggressive outreach. Marketing that pressures a person during a moment of crisis, rather than informing a person making a considered decision, crosses from persuasion into exploitation. Ad copy and landing pages should support an informed decision, not manufacture urgency the underlying clinical situation does not require.
7. Hold Every Outcome Claim to FTC Substantiation Standards
Every statistic in rehab marketing content, from completion rates to relapse-prevention percentages, needs a citable source and methodology behind it. The FTC’s OARFPA enforcement specifically targets unsubstantiated addiction-treatment efficacy claims, and the agency has pursued cases against marketers making claims about treatments quickly, easily, or permanently resolving addiction. A center should retain the underlying data for any published statistic and update or remove the claim if the data changes.
8. Maintain Required Advertising Platform Certification
Google, Meta, and Microsoft Advertising require addiction treatment advertisers to hold current third-party certification before approving addiction treatment ad campaigns, in addition to federal law compliance. Running ads without current certification results in account suspension regardless of whether the underlying marketing content is otherwise compliant. Treatment centers should track certification renewal dates the same way they track state licensing renewal dates.
9. Write Admissions Content in Plain, Non-Manipulative Language
Ethical admissions content explains the treatment process, timeline, and next steps in accessible language, without fear-based pressure tactics or countdown-style urgency devices. A person evaluating treatment options benefits from clear information about what happens during intake, detox, and the first days of treatment. Content that manufactures artificial scarcity, such as false claims of limited bed availability, undermines the trust ethical marketing is built to establish.
Is your facility invisible on Google?
SpikeCrest builds HIPAA-compliant, E-E-A-T verified SEO programs that rank addiction treatment facilities for the keywords their patients are searching — and connect those rankings directly to admissions inquiries.
What Happens When Rehab Marketing Crosses the Line
The FTC’s 2025 enforcement actions show the practical consequences of unethical rehab marketing. In its settlement with Evoke Wellness, the FTC found that the company ran Google search ads impersonating other treatment clinics; when a caller dialed the number expecting to reach the clinic they searched for, telemarketers misled the caller into believing they had reached that clinic before redirecting them to Evoke’s own facilities. The FTC’s separate lawsuit against Mercury Marketing alleged the same impersonation scheme across multiple defendant-operated clinics, deceptively routing consumers away from the treatment center they were trying to reach. Both actions relied on OARFPA, which gives the FTC direct authority over deceptive substance use disorder advertising. Consequences for this category of violation include monetary settlements, injunctions against future advertising practices, and in EKRA cases, criminal prosecution by the Department of Justice.
How to Audit Your Marketing Program for Compliance
A compliance audit for ethical rehab marketing practices reviews four areas in sequence. First, review every outcome claim across the website, ads, and sales scripts for documented supporting data. Second, confirm signed consent forms exist for every published patient testimonial and case study. Third, review all referral, affiliate, and lead-generation payment structures for any fee tied to patient volume, which would violate EKRA. Fourth, confirm current LegitScript or equivalent certification status across every ad platform in use. Centers without an internal compliance owner for this checklist typically assign it to legal counsel or an outside marketing compliance reviewer on a quarterly basis.
FAQs
What is EKRA and how does it affect rehab marketing?
EKRA is the Eliminating Kickbacks in Recovery Act, a 2018 federal law that makes it a felony to pay or receive remuneration for referring a patient to a recovery home, treatment facility, or laboratory. It affects rehab marketing by prohibiting per-referral payments to marketers, call centers, or lead generators, regardless of whether the payer is the treatment center or an affiliate.
Can rehab centers use patient testimonials in marketing?
Rehab centers can use patient testimonials only after obtaining a documented, signed consent under HIPAA and 42 CFR Part 2. The consent must specify what information the patient authorized for marketing use, and the center must remove the testimonial if the patient later revokes consent.
What is patient brokering in addiction treatment?
Patient brokering is the practice of selling or referring an addicted individual to a treatment center in exchange for payment, without regard to clinical fit. EKRA makes patient brokering a federal crime by criminalizing any remuneration tied to a patient referral.
Do rehab centers need certification to run addiction treatment ads?
Rehab centers need third-party certification, most commonly LegitScript certification, before Google, Meta, or Microsoft Advertising will approve addiction treatment ad campaigns. This platform requirement applies on top of, not instead of, federal EKRA and FTC compliance.
What happens if a treatment center violates FTC advertising rules?
A treatment center that violates FTC advertising rules under OARFPA faces potential lawsuits, monetary settlements, and injunctions restricting future advertising practices. The FTC’s 2025 actions against Evoke Wellness and Mercury Marketing both resulted from deceptive search ad practices that impersonated competing clinics.
Is it legal to buy addiction treatment leads from a third-party list?
Buying addiction treatment leads from a purchased contact list is not itself illegal, but paying a fee contingent on how many of those leads convert to admitted patients violates EKRA. Ethical lead generation relies on opt-in contact from individuals who initiated contact, not purchased or scraped contact data.
How does 42 CFR Part 2 affect rehab marketing content?
42 CFR Part 2 restricts the disclosure of substance use disorder patient records, which includes any marketing content that identifies a specific patient. SAMHSA’s 2024 final rule requires a documented patient consent before any such disclosure, with enforcement of the updated requirements beginning February 2026.
Conclusion
Ethical rehab marketing practices are not a separate strategy from effective marketing; they are the compliance floor every legally operating treatment center must meet before optimizing for conversions. Centers that build claims, consent, referral payments, and ad certification around EKRA, FTC, and HIPAA requirements avoid the enforcement actions now shaping the category.
SpikeCrest builds SEO and content programs for addiction treatment centers that are grounded in verified data and compliant marketing practices from the outset, including PPC ad copy that meets LegitScript and EKRA requirements. Contact SpikeCrest to review your current marketing program against these ethical and regulatory standards.
Sources
- U.S. Congress, S.3254 — Eliminating Kickbacks in Recovery Act of 2018: https://www.congress.gov/bill/115th-congress/senate-bill/3254/text
- Federal Trade Commission, “Enforcing the Opioid Addiction Recovery Fraud Prevention Act: The FTC’s settlement with Evoke Wellness” (2025): https://www.ftc.gov/business-guidance/blog/2025/06/enforcing-opioid-addiction-recovery-fraud-prevention-act-ftcs-settlement-evoke-wellness-what-it
- Federal Trade Commission, “FTC Sues to Stop Mercury Marketing and Others from Deceptively Advertising Substance Use Disorder Treatment Clinics” (2025): https://www.ftc.gov/news-events/news/press-releases/2025/06/ftc-sues-stop-mercury-marketing-others-deceptively-advertising-substance-use-disorder-treatment
- Federal Register, “Confidentiality of Substance Use Disorder (SUD) Patient Records,” 42 CFR Part 2 Final Rule (2024): https://www.federalregister.gov/documents/2024/02/16/2024-02544/confidentiality-of-substance-use-disorder-sud-patient-records
- U.S. Department of Health and Human Services, “Marketing,” HIPAA for Professionals FAQ: https://www.hhs.gov/hipaa/for-professionals/faq/marketing/index.html
- Substance Abuse and Mental Health Services Administration, Find Help and Treatment Locator: https://www.samhsa.gov/find-help
